Editorial

iMedPub Journals Journal of Rare Disorders: Diagnosis & Therapy 2020 www.imedpub.com ISSN 2380-7245 Vol.6 No.4:6

DOI: 10.36648/2380-7245.6.4.203

Editorial on Wolfram Syndrome Sophia Roberts Managing Editor, Journal of Rare Disorders: Received: July 05, 2020; Accepted: July 16, 2020; Published: July 24, 2020 Diagnosis & Therapy, United Kingdom

Editorial *Corresponding author: Sophia Roberts Wolfram syndrome or DIDMOAD syndrome a rare that is typically associated with childhood-onset -  [email protected] dependent mellitus and progressive optic atrophy. People with Wolfram syndrome often also have pituitary gland Tel: +44 7480022449 dysfunction that results in the excretion of excessive amounts of urine (), loss caused by changes in the inner ear. There are 2 types of WS may be distinguished: type 1 Managing Editor, Journal of Rare Disorders: (WS1) and type 2 (WS2). Diagnosis & Therapy, United Kingdom. This syndrome is caused by the mutations in theWFS1 gene that is responsible for more than 90 percent of Wolfram syndrome type 1 cases. WFS1 gene provides instructions for producing a protein Citation: Roberts S (2020) Editorial on called wolframin and regulate the amount of calcium in cells. A Wolfram Syndrome. J Rare Disord Diagn proper calcium balance is required for many different cellular Ther Vol.6 No.4:6 functions i.e. protein processing, cell-to-cell communication and the contraction of muscles. CISD2 encodes the ERIS protein and a certain mutation in the CISD2 gene was found to cause A diagnosis is confirmed by genetic screening and based on Wolfram syndrome type 2. ERIS protein has roles in roles in the presence of characteristic . The clinical glucose homeostasis regulation, insulin sensitivity for calcium criteria for WS diagnosis are juvenile-onset diabetes mellitus and homeostasis and autophagy. Wolfram syndrome is inherited in bilateral optical atrophy, family history of Wolfram syndrome or an autosomal recessive pattern. The estimated occurrence of diabetes mellitus and sensorineural [3]. Wolfram syndrome type 1 is 1 in 500,000 people worldwide [1]. Management and treatment of Wolfram syndrome is supportive The primary symptoms of Wolfram syndrome includes diabetes based on the signs and symptoms. It includes an annual screening insipidus, childhood-onset diabetes mellitus, gradual loss of for diabetes mellitus, vision, sensorineural deafness, urodynamic vision due to optic atrophy and deafness. Some others symptoms testing, nephropathy and daily insulin injections and a controlled include: Urinary tract abnormalities, Neurological symptoms, diet to treat diabetes mellitus. People with may Psychiatric and behavioral problems, gastrointestinal problems benefit from hearing aids or cochlear implantation. Treatment of and Disordered sleep etc. [2]. diabetes insipidus, apnea and urinary disorders are needed.

References 2 https://rarediseases.info.nih.gov/diseases/7898/wolfram-syndrome 3 https://rarediseases.org/rare-diseases/wolfram-syndrome/ 1 https://ghr.nlm.nih.gov/condition/wolfram-syndrome

© Under License of Creative Commons Attribution 3.0 License | This article is available in: https://raredisorders.imedpub.com 1